RxDoctor Payments Data

Nicholas Casscells

Orthopaedic Surgery · Washington, DCNPI 1811330996

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,616 of the $3,611 with a category attached, or 72.4%. 13 manufacturers reported payments, led by Stryker at 38.5% of the total. 2025 is the largest year on record at $1,572, 5.0 times the $313 reported in 2019. That places this record below the midpoint for orthopaedic surgery clinicians in DC, where the typical reported total is $4,260.

$3,611in general payments, 2019–2025

Across 50 payments — averaging $72.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1K
  • Vericel Corporation$995
  • Paragon 28, Inc.$279
  • Si-bone, Inc.$146
  • Medline Industries LP$143
  • Smith+Nephew$140
  • plus $518 from 7 others

What the payments were for

  • Travel & lodging$99528%
  • Food & beverage$2,61672%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,611 in reported general payments places this provider in the 45th percentile of 46 orthopaedic surgery providers in District of Columbia.

See all orthopaedic surgery providers in District of Columbia

Medicare billing

Part B allowed, 2024
$121,713
Medicare patients
352
Services billed
779

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium23$405
Celecoxib18$299
Meloxicam69$108
Ondansetron Hcl16$69
Oxycodone Hcl18$67

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →